Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 2,500 shares at $82.00 ($207K) on 2021-04-06, disclosed to the SEC on 2021-04-07.
Open-market sale of $207k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.40 | 1,246 | $104K | 50.3% |
| 2 | $82.00 | 1,254 | $103K | 49.7% |
| Total | $82.70 avg | 2,500 | $207K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |